Numinus Wellness Inc. (NUMI.TO)
| Previous Close | 0.0650 |
| Open | 0.0700 |
| Bid | 0.0650 x N/A |
| Ask | 0.0750 x N/A |
| Day's Range | 0.0650 - 0.0700 |
| 52 Week Range | 0.0600 - 0.2650 |
| Volume | |
| Avg. Volume | 618,995 |
| Market Cap | 22.439M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1000 |
| Earnings Date | Jul 15, 2024 - Jul 19, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupNuminus Wellness Announces Voting Results From its Annual General Meeting of Shareholders
Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is pleased to announce the voting results from its annual general meeting of shareholders (the "Meeting"), held earlier today. A total of 50,266,506 common shares representing 15.68% of the 320,551,600 issued and outstanding common shares of the Company as
- Baystreet
Stocks in play: Numinus Wellness Inc.
Announces that Health Canada has approved the Company's Clinical Trial Application to examine the feasibility ...
NewsfileNuminus Wellness Charts Path To Profitability While Strengthening Community Ties
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus'' or the "Company"), a leader in mental health care and in advancing evidence-based psychedelic-assisted therapies, announces a strategic blueprint aimed at fortifying its footprint across the United States.Through a comprehensive cost optimization initiative, Numinus is poised to strengthen its already established network of U.S. wellness clinics and cutting-edge clinical re
